ACTINIUM PHARMACEUTICALS INC - COM (ATNM)

CUSIP: 00507W107

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
3,247,606
Share change
+574,028
Total reported value
$8,018,711
Price per share
$2.47
Number of holders
38
Value change
+$989,986
Number of buys
25
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 00507W107?
CUSIP 00507W107 identifies ATNM - ACTINIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q1 2015

As of 31 Mar 2015, ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,247,606 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Fund Advisors, STATE STREET CORP, NORTHERN TRUST CORP, BlackRock Institutional Trust Company, N.A., Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, TIAA CREF INVESTMENT MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and DAFNA Capital Management LLC. This page lists 38 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.